Douglas E. McBean
Impact in
- Toxicology top 1%
- Forensic Toxicology and Drug Analysis
-
- Neurotransmitter Receptor Influence on Behavior
- Neuroscience and Neuropharmacology Research
Papers in
-
- Neuroscience and Neuropharmacology Research 10
- Neurotransmitter Receptor Influence on Behavior 8
-
- Traumatic Brain Injury and Neurovascular Disturbances 6
- Neuroinflammation and Neurodegeneration Mechanisms 3
- Co-authors
- Paul A. Kelly (14 shared papers)John Sharkey (10 shared papers)Isobel M. Ritchie (11 shared papers)Henry J. Olverman (6 shared papers)Lorna Fyfe (2 shared papers)A. M. Harper (2 shared papers)Jen Tan (1 shared paper)J. M. Armstrong (2 shared papers)
- Journals
- Brain Research (6 papers)Journal of Cerebral Blood Flow & Metabolism (4 papers)Phytotherapy Research (3 papers)Neuroscience (3 papers)British Journal of Pharmacology (3 papers)
- Partner nations
- United KingdomGermanyHungary
In The Last Decade
Douglas E. McBean
26 papers receiving 513 citations
Peers
Comparison fields: 5 of 66
- Toxicology 134
- Cellular and Molecular Neuroscience 237
- Neurology 67
- Pharmacology 94
- Biological Psychiatry 12
Countries citing papers authored by Douglas E. McBean
This map shows the geographic impact of Douglas E. McBean's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Douglas E. McBean with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Douglas E. McBean more than expected).
Fields of papers citing papers by Douglas E. McBean
This network shows the impact of papers produced by Douglas E. McBean. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Douglas E. McBean. The network helps show where Douglas E. McBean may publish in the future.
Co-authors
The 18 scholars most cited alongside Douglas E. McBean, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 26 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1991 | 57 | |
| 2 | 1998 | 56 | |
| 3 | 2006 | 54 | |
| 4 | 2002 | 40 | |
| 5 | 2004 | 37 | |
| 6 | 2007 | 33 | |
| 7 | 1991 | 32 | |
| 8 | 1995 | 28 | |
| 9 | 1990 | 28 | |
| 10 | 1991 | 27 | |
| 11 | 1999 | 21 | |
| 12 | 1988 | 19 | |
| 13 | 1995 | 17 | |
| 14 | 2008 | 17 | |
| 15 | 2006 | 16 | |
| 16 | 1989 | 14 | |
| 17 | 1995 | 10 | |
| 18 | 1991 | 8 | |
| 19 | 1990 | 8 | |
| 20 | 2000 | 5 |
About Douglas E. McBean
Douglas E. McBean is a scholar working on Cellular and Molecular Neuroscience, Neurology, Toxicology, Neurology and Molecular Biology, having authored 26 papers that have together received 543 indexed citations. Recurring topics across this work include Neuroscience and Neuropharmacology Research (10 papers), Neurotransmitter Receptor Influence on Behavior (8 papers), Traumatic Brain Injury and Neurovascular Disturbances (6 papers), Forensic Toxicology and Drug Analysis (6 papers), Neonatal and fetal brain pathology (3 papers), Neuroinflammation and Neurodegeneration Mechanisms (3 papers), Nitric Oxide and Endothelin Effects (2 papers) and Prenatal Substance Exposure Effects (2 papers). The work is most often cited by research in Toxicology (134 citations), Cellular and Molecular Neuroscience (237 citations), Neurology (67 citations), Pharmacology (94 citations) and Biological Psychiatry (12 citations). Douglas E. McBean has collaborated with scholars based in United Kingdom, Germany and Hungary. Frequent co-authors include Paul A. Kelly, John Sharkey, Isobel M. Ritchie, Henry J. Olverman, Lorna Fyfe, A. M. Harper, Jen Tan, J. M. Armstrong, Mary Warnock and A Suter. Their work appears in journals such as Brain Research, Journal of Cerebral Blood Flow & Metabolism, Phytotherapy Research, Neuroscience and British Journal of Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.